It looks like something leaked, maybe you are right, when things go to a price like this, say $10 for instance maybe a secondary. Should be illegal, trading on news not publicly announced, but we seen this before.
Who downgrades by a dollar menu price, LOL, these guys are cheapskates shaking the PTX tree to get some shares freed up. Maybe PTX will not answer their questions at the next CC,
I was thinking those could help, smaller trials like some in EU that focus on results to give labeling for special situations (i.e.- certain strains of bacteria). I think ultimately that cocktails will be needed to swiftly deal a swift blow. Somebody has to be looking at this, it is so cheap and can still draw fifty million in BARDA money.
Some are trying to read up on Zohydro, IMO. I followed the stock and they now have the abuse det. formulation and called a truce with Purdue. It is a nice Oilgopoly for the two, currently. Analyst said Zohydro can sell $100 million per year upcoming. ZGNX reps have been doing a nice job, now they can also sell Silenor and Treximet.
Woow, you did good on that. CEMP, somebody, has to be looking under the hood at them. Maybe PFE, JNJ, Merck already spent it's 9 billion clip on CBST.
PTX could have bought the whole thing at this level now for another $50 milliion do math, this would get rid of future milestones. They can sift through the employees, wouldn't you think?
$30 million cash, $20 million PTX stock, and $50 million IOU due to ZGNX. I think they can make a lot more than this back. PTX also now gets access to ZGNX sales force to help sell Trexi, and Silenor. They can detail Zohydro at the same doctors, the way it is being described. Now ZGNX is very cheap (PTX could have taken the whole company at this low price. That would get rid of future milestones and also get pipeline, probably too complicated now?).
Patch is right, PTX got revived by Dougie Drysdale. Management was key to a fairly fast turnaround. Dougie fixed the board, did some good things here. Growing sales quickly.
Agreed, ZGNX will get $20 million in PTX shares, in addition to $30 million cash and $50 million IOU. ZGNX went through the ringer to get the approval, I know. With low interest rates the IOU makes sense for PTX. ZGNX will focus on Relday and another pipeline project. Hope Relday is a success for ZGNX shareholders, Phase 3 results due next year.
Sentiment: Strong Buy
Yeah, ZGNX has estimated sales on yahoo finance of $59 million for 2015. This is a good deal for PTX. ZGNX will focus on their pipeline and PTX will hopefully grow sales with ZGNX reps. The IP goes out to 2030.
Researcher, ZGNX pain line going to PTX along with the sales force. This may free up some managers from ZGNX? Just a thought as I know you mentioned some AUXL management.
The ZGNX message board doesn't sound happy. They get 30 million cash, a couple million of PTX and a $50 million IOU. I would think they get a % of sales from PTX. They will use the 30 million cash on the pipeline I guess?